CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Christina Bergmann, Armin Atzinger et al.|The Lancet Rheumatology|2024Cited by 96
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Georg Schett, Fabian Müller et al.|The Lancet Rheumatology|2025Cited by 71
Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiationAndrea‐Hermina Györfi, Jörg H. W. Distler|The Journal of Experimental Medicine|2021Cited by 45
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc)Christina Bergmann, Jörg H. W. Distler, Ludwig Hallenberger et al.|Annals of the Rheumatic Diseases|2021Cited by 12